Search results
Find the latest (ZLCS) stock quote, history, news and other vital information to help you with your stock trading and investing.
19 mar 2012 · Here in 2012, Zalicus (ZLCS) is re-emerging on the biotech scene as a great investment opportunity offering substantial gains. I have put together this highly investigative report to explain why...
ZLCS - Forecast, Price Target, Estimates, Predictions. ... Forecasts Analyst Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand. Germany Switzerland Spain Poland Netherlands Greece France Ireland Italy Belgium Austria Israel Türkiye.
10 paź 2012 · Today, Zalicus, Inc. (ZLCS) is trading at $0.52 per share. The basic share count (as of August 6, 2012) is 126.7 million.
EPIRUS Biopharmaceuticals serves customers worldwide. Company profile page for EPIRUS Biopharmaceuticals Inc including stock price, company news, executives, board members, and contact...
Interactive Chart for (ZLCS), analyze all the data with a huge range of indicators.
16 kwi 2014 · Zalicus (ZLCS) soared Wednesday after the biopharmaceutical company announced it would merge with Epirus Biopharmaceuticals.
